Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bioreactor metagenome

ABSTRACT: Produção biotecnológica de hidrogênio a partir do glicerol, bioproduto da produção do biodiesel

PROVIDER: PRJNA322194 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3560105.fastq.gz	Fastqsanger.gz
	SRR3560106.fastq.gz	Fastqsanger.gz
	SRR3615052_1.fastq.gz	Fastqsanger.gz
	SRR3615052_2.fastq.gz	Fastqsanger.gz
	SRR3615053_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Single-cell analysis of human iPSC-derived midbrain organoids generated with triphasic Wnt modulation combined with a dynamic bioreactor

Project description:Human midbrain organoids (hMOs) derived from induced pluripotent stem cells offer a promising platform to model Parkinson’s disease (PD), but current systems often fall short in generating mature, regionally specified dopaminergic (DA) neurons that reflect disease-relevant vulnerabilities. Here, we present a refined differentiation strategy that combines tri-phasic WNT signaling modulation with dynamic bioreactor cultivation to enhance DA neuron yield, specification, and maturation within hMOs. This approach generated DA neurons with enriched substantia nigra-like identity (GIRK2⁺, ALDH1A1⁺), elevated dopamine release, and robust functional activity. Single cell transcriptomic profiling revealed upregulation of synaptic, metabolic, and neuroprotective pathways within the DA neuron cluster, while stress-related and pro-apoptotic programs were suppressed. Importantly, these hMOs exhibited selective vulnerability upon challenge with α-synuclein preformed fibrils (aSyn-PFFs), modeling PD-relevant neurodegeneration. Together, our findings establish a scalable, physiologically relevant platform for investigating PD mechanisms, therapeutic screening and advancing the development of cell replacement strategies.

2026-06-03 | GSE301365 | GEO

A New Zamilon-like Virophage Partial Genome Assembled from a Bioreactor Metagenome.

Project description: Not available

| S-EPMC4661282 | biostudies-literature

Campomanesia adamantium O. Berg

Project description:ANÁLISE METAGENÔMICA DA RIZOSFERA DE GUAVIRA

| PRJEB76277 | ENA

Campomanesia adamantium O. Berg

Project description:ANÁLISE DE GENES 16S rDNA DA RIZOSFERA DE GUAVIRA

| PRJEB75480 | ENA

Samples of biological reactos

Project description:Manutencao da producao de metano em industrias sucroalcooleiras a partir da substituicao de vinhaca por glicerol no periodo de entressafra de cana de acucar

| PRJNA869079 | ENA

Profile of innate immunity in the skin of patients with SARS-CoV-2

Project description:The proposal is to analyse global immunity genes in the RNA sequencing of the skin of patients with SARS-CoV-2 We analyzed 8 samples of skin samples from post-mortem patients from Covid-19 of Hospital das Clinicas da Faculdade de Medicina da USP de Sao Paulo. To compare we used 5 skin biopsy from healthy controls, submitted to plastic surgery.

2026-07-20 | GSE297915 | GEO

activated sludge metagenome

Project description:Daka Biodiesel activated sludge Metagenome

| PRJNA284929 | ENA

sludge metagenome

Project description:Daka Biodiesel activated sludge Metagenome 2

| PRJNA352657 | ENA

Genome of a Novel Bacterium "<i>Candidatus</i> Jettenia ecosi" Reconstructed From the Metagenome of an Anammox Bioreactor.

Project description: Not available

| S-EPMC6828613 | biostudies-literature

Estudo de avaliação do efeito do tratamento profiláctico do rash com o fármaco monociclina em doentes com diagnóstico de cancro colo-rectal metastizado que estejam a receber tratamento com cetuximab.

Project description:Primary objectives: Avaliar a eficácia da abordagem profilática com minociclina no desenvolvimento de toxicidade dermatológica secundária ao cetuximab Primary endpoints: Percentagem de doentes que desenvolvem rash associado ao tratamento com cetuximab para o cancro colo-rectal, no grupo experimental comparativamente com o grupo controlo

| 2529318 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data